...
首页> 外文期刊>Nanotechnology >A multifunctional magnetic nanocarrier bearing fluorescent dye for targeted drug delivery by enhanced two-photon triggered release
【24h】

A multifunctional magnetic nanocarrier bearing fluorescent dye for targeted drug delivery by enhanced two-photon triggered release

机译:带有荧光染料的多功能磁性纳米载体,可通过增强的双光子触发释放来靶向药物递送

获取原文
获取原文并翻译 | 示例
           

摘要

We report a novel nanoformulation for targeted drug delivery which utilizes nanophotonics through the fusion of nanotechnology with biomedical application. The approach involves an energy-transferring magnetic nanoscopic co-assembly fabricated of rhodamine B (RDB) fluorescent dye grafted gum arabic modified Fe_3O_4 magnetic nanoparticle and photosensitive linker by which dexamethasone drug is conjugated to the magnetic nano-assembly. The advantage offered by this nanoformulation is the indirect photo-triggered-on-demand drug release by efficient up-converting energy of the near-IR (NIR) light to higher energy and intraparticle energy transfer from the dye grafted magnetic nanoparticle to the linker for drug release by cleavage. The synthesized nanoparticles were found to be of ultra-small size (13.33 nm) and are monodispersed in an aqueous suspension. Dexamethasone (Dexa) drug conjugated to RDB–GAMNP by photosensitive linker showed appreciable release of Dexa by photo-triggered response on exposure to radiation having a wavelength in the NIR region whereas no detectable release was observed in the dark. Photo-triggered response for the nanoformulation not bearing the rhodamine B dye was drastically less as less Dexa was released on exposure to NIR radiation which suggest that the photo-cleavage of linker and release of Dexa mainly originated from the indirect excitation through the uphill energy conversions based on donor–acceptor model FRET. The promising pathway of nanophotonics for the on-demand release of the drug makes this nanocarrier very promising for applications in nanomedicine.
机译:我们报告了一种针对靶向药物输送的新型纳米制剂,该制剂通过纳米技术与生物医学应用的融合利用了纳米光子学。该方法涉及由若丹明B(RDB)荧光染料接枝的阿拉伯树胶改性的Fe_3O_4磁性纳米粒子和光敏连接器制成的能量转移磁性纳米共组装体,地塞米松药物通过该连接体与磁性纳米组装体结合。这种纳米配方的优势是通过将近红外(NIR)光的能量有效上转换为更高的能量,以及从染料接枝的磁性纳米粒子到连接子的连接子的粒子内能量转移,从而间接进行按需光触发的药物释放。通过分裂释放药物。发现合成的纳米颗粒具有超小尺寸(13.33nm),并且被单分散在水性悬浮液中。通过光敏接头偶联到RDB-GAMNP的地塞米松(Dexa)药物在暴露于NIR区域波长的辐射时,通过光触发响应显示出明显的Dexa释放,而在黑暗中未观察到释放。不含罗丹明B染料的纳米配方的光触发响应大大降低,因为暴露于NIR辐射下释放的Dexa更少,这表明连接基的光裂解和Dexa的释放主要源于通过上坡能量转换的间接激发基于供体-受体模型FRET。纳米光子学用于按需释放药物的有前途的途径使得这种纳米载体在纳米医学中的应用非常有前途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号